[Subacute sclerosing panencephalitis cases diagnosed by increased CSF/serum measles antibody indices]

Mikrobiyoloji Bulteni
|November 29, 2012
PubMed

Insights

Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder. Diagnosing SSPE involves detecting increased measles-specific antibodies in serum and cerebrospinal fluid (CSF), highlighting the importance of measles vaccination for prevention.

Area of Science:

  • Neurology
  • Virology
  • Immunology

Context:

  • Subacute sclerosing panencephalitis (SSPE) is a rare, fatal neurological deterioration in children and adolescents.
  • It is caused by persistent, defective measles virus strains.
  • Early and accurate diagnosis is critical for patient management.

Purpose:

  • To report diagnostic data from SSPE-suspected cases.
  • To confirm SSPE diagnosis through elevated antibody index in serum and cerebrospinal fluid (CSF).
  • To emphasize the role of measles vaccination in SSPE prevention.

Summary:

  • Eleven patients with suspected SSPE were analyzed for measles-specific IgG antibodies in serum and CSF.
  • Elevated CSF/serum indices (CSQrel ≥ 1.5) confirmed intrathecal measles antibody synthesis in seven (63.6%) patients.
  • Unvaccinated patients with measles infection showed a higher risk and varied latency periods for SSPE development.

Impact:

  • Demonstrates the diagnostic utility of increased measles antibody index in serum and CSF for SSPE.
  • Reinforces that effective measles vaccination is the sole preventive measure against measles and SSPE.
  • Provides crucial data for understanding SSPE pathogenesis and prevention strategies.